Who Owns BLTE?

Belite Bio, Inc — Institutional Ownership & 13F Holdings

$160.59

-4.25 (-2.58%)

Market Cap

$6.7B

Shares Outstanding

39,965,311

Institutional Holders

18

Total Inst. Value

$11.4M

% of Float Held

QoQ Holder Change

+7

Institutional data as of Q1 2025

New Positions

7

Closed Positions

12

Increased

5

Decreased

5

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Alyeska Investment Group, L.P.New$5.5M83,623
2GAMMA Investing LLC$1.8M122,441
3STATE STREET CORP$1.3M20,098
4GEODE CAPITAL MANAGEMENT, LLC$844K12,753
5JPMORGAN CHASE & CO$540K8,162
6CITADEL ADVISORS LLC$377K5,689
7BANK OF AMERICA CORP /DE/$345K5,224
8AMERIPRISE FINANCIAL INCNew$204K3,075
9Virtus Investment Advisers, LLCNew$171K2,589
10RHUMBLINE ADVISERS$95K1,435

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue
BANK OF AMERICA CORP /DE/-13K$345K
UBS Group AG-12K$36K
MORGAN STANLEY-10K$19K
JPMORGAN CHASE & CO-6K$540K
OSAIC HOLDINGS, INC.-1$397

Related Stocks

Frequently Asked Questions

How many institutional investors hold BLTE?

As of Q1 2025, 18 institutional investors report holding BLTE (Belite Bio, Inc) in their 13F filings.

Which hedge fund owns the most BLTE?

The largest institutional holder of BLTE is Alyeska Investment Group, L.P. with $5.5M in shares.

Are institutions buying or selling BLTE?

This quarter, 7 institutions opened new positions in BLTE and 12 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.